Skip to content

Optimization of ERAS management model in the perioperative period of pediatric day surgery: evaluating the effectiveness and safety of low-opioid multimodal analgesia strategy.

Optimization of ERAS management model in the perioperative period of pediatric day surgery: evaluating the effectiveness and safety of low-opioid multimodal analgesia strategy.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600115977
Enrollment
Unknown
Registered
2026-01-04
Start date
2026-01-06
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Low-opioid group (experimental group):Preoperative medication: 2-3 hours preoperatively, administer acetaminophen oral solution (10 mg/kg). Induction phase: Esketon 0.2 mg/kg + dexmedetomidine 0.5-1.0
Traditional group (control group):Preoperative medication: No routine analgesics. Induction phase: Propofol 2-3 mg/kg + Fentanyl 3 µg/kg + Rocuronium 0.6 mg/kg Intraoperative maintenance: Propofol 80
fentanyl may be added as needed based on clinical symptoms. Postoperative analgesia: At the end of surgery: Fentanyl 0.5 µg/kg IV Postoperative routine medication: Acetaminophen 10 mg/kg orally, q6h

Sponsors

Hubei Provincial Maternal and Child Health Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 12 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria 1.Age 2-12 years, gender not limited 2.ASA classification I-II (good health or mild systemic disease) 3.Planned elective day surgery, estimated surgery time 30-120 minutes 4.Inguinal hernia repair 5.Circumcision 6.Excision of superficial masses 7.Informed consent signed by the child's legal guardian

Exclusion criteria

Exclusion criteria: 4.2 Exclusion Criteria 1.History of allergy or contraindication to any of the drugs mentioned in the study protocol 2.Severe hepatic or renal insufficiency (ALT/AST > 2 times the upper limit of normal) 3. Coagulation disorders (INR > 1.5, platelets 95th) 8. Positive predictor of difficult airway

Design outcomes

Primary

MeasureTime frame
Pain score;

Secondary

MeasureTime frame
Postoperative nausea and vomiting (PONV) incidence;Recovery indicators;Analgesic usage;Patient family satisfaction;Cost-benefit indicators;Sleep quality assessment;Long-term behavioral change;

Countries

China

Contacts

Public ContactShen Chan

Hubei Provincial Maternal and Child Health Care Hospital

sunnyabs1215@163.com+86 189 8616 1976

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026